Safer opioids may be on the horizon, but mitigating addiction is a long shot
Author:
- Jyoti MadhusoodananJMJyoti Madhusoodanan
- 14 August 2018
- journal article
- editorial
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 115 (33) , 8229-8231
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- Helping to End Addiction Over the Long-termJAMA, 2018
- Functional Divergence of Delta and Mu Opioid Receptor Organization in CNS Pain CircuitsNeuron, 2018
- A randomized, Phase IIb study investigating oliceridine (TRV130), a novel µ-receptor G-protein pathway selective (µ-GPS) modulator, for the management of moderate to severe acute pain following abdominoplastyJournal of Pain Research, 2017
- Breaking barriers to novel analgesic drug developmentNature Reviews Drug Discovery, 2017
- A nontoxic pain killer designed by modeling of pathological receptor conformationsScience, 2017
- Loss of μ opioid receptor signaling in nociceptors, but not microglia, abrogates morphine tolerance without disrupting analgesiaNature Medicine, 2017
- Mu Opioids and Their Receptors: Evolution of a ConceptPharmacological Reviews, 2013
- N -naphthoyl-β-naltrexamine (NNTA), a highly selective and potent activator of μ/κ-opioid heteromersProceedings of the National Academy of Sciences, 2011